BIOMARIN PHARMACEUTICAL INC Current Liabilities
BIOMARIN PHARMACEUTICAL INC (BMRN) had Current Liabilities of $1.66 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $1.66B.
- 2026-03-31: Liabilities, Current $793.15M.
- 2025-12-31: Liabilities, Current $759.03M.
- 2025-09-30: Liabilities, Current $798.44M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.66B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $793.15M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $759.03M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $798.44M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $684.25M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $628.21M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $606.99M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $715.66M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $1.07B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $1.09B 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $1.18B 10-K · filed 2025-02-24 | |
| 2023-09-30 | $1.16B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $597.23M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $598.23M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $588.88M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $521.02M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $464.73M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $490.42M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $546.50M 10-K · filed 2023-02-27 | $539.82M 10-K · filed 2022-02-25 |
| 2021-09-30 | $514.90M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $443.34M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $430.04M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $492.55M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $854.69M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $813.30M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $820.47M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $932.50M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $493.75M 10-Q/A · filed 2019-11-04 | |
| 2019-06-30 | $439.43M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $500.99M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $523.24M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $838.66M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $804.95M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $773.47M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $816.52M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $417.53M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $374.30M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $340.21M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $439.31M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $377.33M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $364.58M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $388.01M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $445.46M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $390.49M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $347.70M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $305.51M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $235.74M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $206.55M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $166.72M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $156.04M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $183.27M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $167.63M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $142.24M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $144.01M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $170.43M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $134.93M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $120.00M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $119.81M 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $94.13M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $83.25M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $82.03M 10-Q · filed 2011-08-01 | |
| 2011-03-31 | $75.99M 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $83.84M 10-K · filed 2012-02-22 | |
| 2010-09-30 | $92.10M 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $83.93M 10-Q · filed 2010-08-04 | |
| 2009-12-31 | $78.15M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |